Asia Spotlight: Foreign Firms Among Casualties As China FDA Clears Clinical Data Smog
Executive Summary
Although products from foreign pharma companies in general are considered to be of high quality in China, a number of such firms, including India’s Sun Pharma, have retracted product registration applications as regulatory authorities widen a crackdown on the quality of clinical data in filings.